This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dsm IP Assets B.v.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Ellen Speetjens: Innovator in Yeast Cell Wall Treatment
Introduction
Ellen Speetjens is a notable inventor based in Echt, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the treatment of yeast cell walls. With a total of 2 patents to her name, her work has implications for various applications in the industry.
Latest Patents
Ellen's latest patents focus on a process for the treatment of yeast cell walls using laminaripentaose-producing beta-1,3-glucanase. This innovative process involves treating a composition of yeast cell walls that contain insoluble beta-1,3-glucans when extracted with water and partially soluble when extracted with DMSO. The method enhances the solubility of these glucans in DMSO, achieving a ratio of beta-glucans soluble in DMSO compared to water that is greater than or equal to 2.
Career Highlights
Ellen Speetjens is currently associated with DSM IP Assets B.V., where she continues to advance her research and development efforts. Her work is pivotal in enhancing the understanding and application of yeast cell wall treatments.
Collaborations
Ellen collaborates with Peter Philip Lankhorst, contributing to the innovative projects at their company. Their teamwork exemplifies the synergy between inventors in the field.
Conclusion
Ellen Speetjens is a prominent figure in the biotechnology sector, with her patents paving the way for advancements in yeast cell wall treatment. Her contributions are vital for future innovations in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile